Lab On-Chip and Microarrays Market : By Product Type (Lab-On-A-Chips (PDMS Lab-On-A-Chip, Thermo Polymers Lab-On-A-Chip, Glass LAB-ON-A-CHIP, Silicon Lab-On-A-Chip, Paper Lab-On-A-Chip) Microarrays (DNA Microarrays, Tissue Microarrays, Protein Microarray, Others)), By End User (Biotechnology and Pharmaceutical Firms, Academic and Research Institutions, Hospitals and Diagnostic Centres) and Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Lab On-Chip And Microarrays Market size was valued at USD 17.32 billion in 2023 and is poised to grow at a significant CAGR of 13.6% from 2024-2030. Lab on the chip an evolutionary device which integrates single or many laboratory functions on one integrated circuit commonly, a cSizhip. Lab-on-chip generally measures about few square centimetres and used to achieve automation and high through screening. The microarray is the most recent advances in the cancer research. Microarrays help to analyse plenty of samples which have already been recorded or new samples, it even helps to test the incidence of a particular marker in tutors. There are two types of microarrays, gene expression microarrays and tissue microarrays. The lab on-chip and microarrays market has very few and dominant players who are actively participating in research and development of the new products. Companies are launching the new products to increase the market share.  

Lab On-Chip And Microarrays Market Key Developments:

  • In November 2016, Abbott laboratories received CE mark for its innovative blood testing device i-STAT Alinity point of care system, a portable device that can perform and analyse largest menu of blood tests on a single device. Furthermore, companies are collaborating in the development of the new products.
  • In March 2016, CombiMatrix Molecular Diagnostics (CMDX) and Array Genomics Inc. entered into the collaboration agreement to develop and market a series of comparative genomic hybridization (CGH) microarray products.

Lab On Chip And Microarrays Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

13.6%

Largest Market

North America

Fastest Growing Market

Europe
Lab On Chip And Microarrays Market Dynamics

Global lab on chip and microarrays market is mainly driven by the increase in the adaptation of lab on chip and microarrays in various research fields such as drug discovery, genomics, proteomics and others. In addition, increase in demand for personalized medicine and increase in prevalence rates of cancer that led to the demand for the development of R&D related to cancer diagnostics and treatment expected to boost the global lab on chip and microarrays market over the forecast period. However, a high cost of devices and stringent regulations for research on genomes are expected to hamper the market growth over the forecast period.

Lab On Chip And Microarrays Market Segmentation

By Product Type
  • Lab-On-A-Chips
    • PDMS Lab-On-A-Chip
    • Thermo Polymers Lab-On-A-Chip
    • Glass LAB-ON-A-CHIP
    • Silicon Lab-On-A-Chip
    • Paper Lab-On-A-Chip
  • Microarrays
    • DNA Microarrays
    • Tissue Microarrays
    • Protein Microarray
    • Others
By End User
  • Biotechnology and Pharmaceutical Firms
  • Academic and Research Institutions
  • Hospitals and Diagnostic Centres
By Geography
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Frequently Asked Questions

The Lab on-chip and microarrays market size was valued at USD 17.32 billion in 2023

The key segments covered in the lab on-chip and microarrays market are technology, components, application, and end-users.

The Lab on-chip and microarrays market key players are Affymetrix Inc. (U.S.), Abbott Laboratories (U.S.), Agilent Technologies (U.S.), Biomerieux SA (France), Beckman Coulter Inc. (U.S.), CombiMatrix Molecular Diagnostics (CombiMatrix Corp.) (U.S.)

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Lab On-Chip And Microarrays Market Introduction 
2.1.Global Lab On-Chip And Microarrays Market  - Taxonomy
2.2.Global Lab On-Chip And Microarrays Market  - Definitions
2.2.1.Product Type
2.2.2.End User
2.2.3.Region
3.Global Lab On-Chip And Microarrays Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Lab On-Chip And Microarrays Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Lab On-Chip And Microarrays Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Lab-On-A-Chips
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Microarrays
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Lab On-Chip And Microarrays Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Biotechnology and Pharmaceutical Firms
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Academic and Research Institutions
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Hospitals and Diagnostic Centres
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Lab On-Chip And Microarrays Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Lab-On-A-Chips
8.1.2.Microarrays
8.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Biotechnology and Pharmaceutical Firms
8.2.2.Academic and Research Institutions
8.2.3.Hospitals and Diagnostic Centres
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Lab-On-A-Chips
9.1.2.Microarrays
9.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Biotechnology and Pharmaceutical Firms
9.2.2.Academic and Research Institutions
9.2.3.Hospitals and Diagnostic Centres
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
9.3.6.Rest of EU
10.Asia Pacific (APAC) Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Lab-On-A-Chips
10.1.2.Microarrays
10.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Biotechnology and Pharmaceutical Firms
10.2.2.Academic and Research Institutions
10.2.3.Hospitals and Diagnostic Centres
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Lab-On-A-Chips
11.1.2.Microarrays
11.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Biotechnology and Pharmaceutical Firms
11.2.2.Academic and Research Institutions
11.2.3.Hospitals and Diagnostic Centres
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Lab On-Chip And Microarrays Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Lab-On-A-Chips
12.1.2.Microarrays
12.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Biotechnology and Pharmaceutical Firms
12.2.2.Academic and Research Institutions
12.2.3.Hospitals and Diagnostic Centres
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Affymetrix Inc. (U.S)
13.2.2.Abbott Laboratories (U.S)
13.2.3.Agilent Technologies (U.S)
13.2.4.Biomerieux SA (France)
13.2.5.Beckman Coulter Inc. (U.S)
13.2.6.CombiMatrix Molecular Diagnostics (CombiMatrix Corp) (U.S)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Affymetrix Inc.
  • Abbott Laboratories
  • Agilent Technologies
  • Biomerieux SA (France)
  • Beckman Coulter Inc.
  • CombiMatrix Molecular Diagnostics (CombiMatrix Corp)

Adjacent Markets